29 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C … that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted
ARS
i3qv2uyk
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
d4xqb2qf
11 Apr 23
Preliminary proxy
5:49pm
S-3
EX-4.4
ad1tmbcg64fc7q8x
24 Aug 22
Shelf registration
4:07pm
S-3
EX-4.5
aaln804o c8z6o
24 Aug 22
Shelf registration
4:07pm
DEF 14A
bebi4q4iocz0yeqpk351
26 Apr 22
Definitive proxy
4:39pm
10-K
qiejr0xk qp6z1
22 Mar 22
Annual report
5:20pm
10-Q
obsqvbl81rbqzrhez
7 Sep 21
Quarterly report
8:48am
424B4
1cs89
23 Jul 21
Prospectus supplement with pricing info
4:49pm
CORRESP
vxxjcpnj07363
19 Jul 21
Correspondence with SEC
12:00am